Gastroesophageal reflux disease(GERD)poses a substantial global health challenge,with prevalence rates exhibiting geographical variation.Despite its widespread recognition,the exact prevalence and associated risk fact...Gastroesophageal reflux disease(GERD)poses a substantial global health challenge,with prevalence rates exhibiting geographical variation.Despite its widespread recognition,the exact prevalence and associated risk factors remain elusive.This article comprehensively analyzed the global burden of GERD,shedding light on its risk factors,underlying pathophysiological mechanisms,current diagnostic modalities,evolving management strategies tailored to diverse patient profiles,and complex determinants contributing to treatment failures.A deeper comprehension of GERD is achieved by dissecting these intricate facets,paving the way for enhanced clinical management and improved patient outcomes.展开更多
The exact worldwide prevalence of gastroesophageal reflux disease(GERD)re-mains uncertain,despite its recognition as a common condition.This conundrum arises primarily from the lack of a standardized definition for GE...The exact worldwide prevalence of gastroesophageal reflux disease(GERD)re-mains uncertain,despite its recognition as a common condition.This conundrum arises primarily from the lack of a standardized definition for GERD.The gold standard diagnostic tests for GERD,such as pH impedance testing and endo-scopy,are cumbersome and impractical for assessing community prevalence.Consequently,most epidemiological studies rely on symptom-based screening tools.GERD symptoms can be both esophageal and extraesophageal,varying widely among individuals.This variability has led to multiple symptom-based definitions of GERD,with no consensus,resulting in prevalence estimates ranging from 5%to 25%worldwide.Most systematic reviews define GERD as experi-encing heartburn and/or regurgitation at least once weekly,yielding a calculated prevalence of 13.98%.In 2017,the global age-standardized prevalence of GERD was estimated at 8819 per 100000 people(95%confidence interval:7781-9863),a figure that has remained stable from 1990 to 2017.Prevalence increases with age,leading to more years lived with disability.GERD significantly impairs quality of life and can lead to multiple complications.Additionally,it imposes a severe economic burden,with the United States alone estimated to spend around 10 billion dollars annually on diagnosis and treatment.In summary,GERD preva-lence varies greatly by region and even within different areas of the same province.Determining the exact prevalence is challenging due to inconsistent diagnostic criteria.However,it is well-documented that GERD poses a significant global burden,affecting the quality of life of individuals and creating a substantial healthcare cost.展开更多
文摘Gastroesophageal reflux disease(GERD)poses a substantial global health challenge,with prevalence rates exhibiting geographical variation.Despite its widespread recognition,the exact prevalence and associated risk factors remain elusive.This article comprehensively analyzed the global burden of GERD,shedding light on its risk factors,underlying pathophysiological mechanisms,current diagnostic modalities,evolving management strategies tailored to diverse patient profiles,and complex determinants contributing to treatment failures.A deeper comprehension of GERD is achieved by dissecting these intricate facets,paving the way for enhanced clinical management and improved patient outcomes.
文摘The exact worldwide prevalence of gastroesophageal reflux disease(GERD)re-mains uncertain,despite its recognition as a common condition.This conundrum arises primarily from the lack of a standardized definition for GERD.The gold standard diagnostic tests for GERD,such as pH impedance testing and endo-scopy,are cumbersome and impractical for assessing community prevalence.Consequently,most epidemiological studies rely on symptom-based screening tools.GERD symptoms can be both esophageal and extraesophageal,varying widely among individuals.This variability has led to multiple symptom-based definitions of GERD,with no consensus,resulting in prevalence estimates ranging from 5%to 25%worldwide.Most systematic reviews define GERD as experi-encing heartburn and/or regurgitation at least once weekly,yielding a calculated prevalence of 13.98%.In 2017,the global age-standardized prevalence of GERD was estimated at 8819 per 100000 people(95%confidence interval:7781-9863),a figure that has remained stable from 1990 to 2017.Prevalence increases with age,leading to more years lived with disability.GERD significantly impairs quality of life and can lead to multiple complications.Additionally,it imposes a severe economic burden,with the United States alone estimated to spend around 10 billion dollars annually on diagnosis and treatment.In summary,GERD preva-lence varies greatly by region and even within different areas of the same province.Determining the exact prevalence is challenging due to inconsistent diagnostic criteria.However,it is well-documented that GERD poses a significant global burden,affecting the quality of life of individuals and creating a substantial healthcare cost.
